Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-10-19

Clinical Trial Update: Testosterone Regulation of the Natriuretic Peptide System [NA]

View source ↗

Summary

A clinical trial investigating testosterone regulation of the natriuretic peptide system for hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hypertension | NA | Status: WITHDRAWN